Показано 0 из 0
Дата |
---|
03.05.2024 |
02.05.2024 |
01.05.2024 |
30.04.2024 |
29.04.2024 |
26.04.2024 |
25.04.2024 |
24.04.2024 |
23.04.2024 |
22.04.2024 |
Bid | Ask |
Open |
Min | Max |
Last |
Legal close |
Avg |
Оборот |
Кол-во сделок |
---|---|---|---|---|---|---|---|
2.01
|
2.06
|
2.05
|
2.00
|
2.13
|
2.03
|
|
|
3 044 741.01
|
7 114.00
|
2.00
|
2.04
|
1.96
|
1.93
|
2.05
|
2.00
|
|
|
3 852 034.36
|
6 892.00
|
1.90
|
1.93
|
1.82
|
1.80
|
1.975
|
1.93
|
|
|
3 468 333.61
|
10 311.00
|
1.80
|
1.84
|
1.92
|
1.81
|
1.97
|
1.81
|
|
|
3 520 851.14
|
10 273.00
|
1.88
|
1.93
|
1.79
|
1.76
|
1.98
|
1.90
|
|
|
3 990 802.18
|
9 971.00
|
1.77
|
1.84
|
1.79
|
1.70
|
1.84
|
1.76
|
|
|
9 092 861.85
|
10 775.00
|
1.77
|
1.80
|
1.87
|
1.76
|
1.91
|
1.78
|
|
|
4 464 858.57
|
11 769.00
|
1.87
|
1.90
|
1.97
|
1.87
|
1.99
|
1.88
|
|
|
3 314 562.17
|
7 900.00
|
1.95
|
1.98
|
1.97
|
1.94
|
2.02
|
1.95
|
|
|
2 908 837.42
|
8 273.00
|
1.97
|
2.01
|
1.90
|
1.90
|
2.025
|
1.98
|
|
|
3 078 898.47
|
8 699.00
|
Amylyx Pharmaceuticals, Inc. is a clinical-stage pharmaceutical company working on developing a novel therapeutic for amyotrophic lateral sclerosis (ALS) and other neurodegenerative diseases.